Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Entire DC Network
Editorial Comment: Laparoscopic Single Port Cystolithotomy Using Pneumovesicum, Trushar Patel
Editorial Comment: Laparoscopic Single Port Cystolithotomy Using Pneumovesicum, Trushar Patel
Urology Faculty Publications
No abstract provided.
Retroperitoneoscopic Pyelolithotomy: A Good Alternative Treatment For Renal Pelvic Calculi In Children, Lucas Wiegand
Retroperitoneoscopic Pyelolithotomy: A Good Alternative Treatment For Renal Pelvic Calculi In Children, Lucas Wiegand
Urology Faculty Publications
No abstract provided.
A Rare Case Of The Simultaneous, Multifocal, Metastatic Renal Cell Carcinoma To The Ipsilateral Left Testes, Bladder, And Stomach, Michael Kongnyuy, Samuel Lawindy, Daniel Martinez, Mary Hall
A Rare Case Of The Simultaneous, Multifocal, Metastatic Renal Cell Carcinoma To The Ipsilateral Left Testes, Bladder, And Stomach, Michael Kongnyuy, Samuel Lawindy, Daniel Martinez, Mary Hall
Urology Faculty Publications
We describe the rare case of a 68-year-old gentleman with the history of a hand-assisted laparoscopic left radical nephrectomy for a T2bN0M1 clear cell renal cell carcinoma (RCC). Seven years after surgery and with clean surveillance imaging for metastasis/recurrence the patient presented with three separate tumors suspicious for malignancy. A bladder lesion was found during workup for hematuria, a stomach lesion during diagnostic endoscopy, and a testicular lesion during self-exam. He underwent transurethral resection of bladder tumor, left inguinal orchiectomy, and upper endoscopic ensnarement. All specimens surprisingly showed RCC by histology and immunostaining. These three sites are rare for RCC …
Randomized, Placebo-Controlled Trial Evaluating The Safety Of One-Year Administration Of Green Tea Catechins, Nagi B. Kumar, Julio Pow-Sang, Philippe E. Spiess, Jong Park, Raoul Salup, Christopher R. Williams, Howard Parnes, Michael J. Schell
Randomized, Placebo-Controlled Trial Evaluating The Safety Of One-Year Administration Of Green Tea Catechins, Nagi B. Kumar, Julio Pow-Sang, Philippe E. Spiess, Jong Park, Raoul Salup, Christopher R. Williams, Howard Parnes, Michael J. Schell
Urology Faculty Publications
Purpose: Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, regulatory bodies have required stringent inclusion criteria with frequent, excessive toxicity monitoring and early stopping rules in clinical trials. These requirements have impeded recruitment and retention of subjects in chemoprevention trials and subsequent progress in agent development efforts.
Experimental Design: We conducted a placebo-controlled, randomized clinical trial of Polyphenon E® (PolyE®), a proprietary mixture of decaffeinated GTCs, containing 400 mg (−)-epigallocatechin-3-gallate …